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14-3-3s predominantly form homo-/heterodimers that are in equilibrium with corresponding
monomers. Dimer/monomer equilibrium depends on the nature and phosphorylation of Ser58 of
certain 14-3-3 isoforms. The structure and properties of 14-3-3 dimers are well characterized,
whereas 14-3-3 monomers are less investigated. Therefore design and analysis of dimer-incapable
mutants of 14-3-3 are important. Truncated or heavily mutated proteins are not ideal since their
structure may be distorted. Phosphomimicking mutations, such as S58(D/E), induce incomplete
dimer dissociation. A recently characterized monomeric 14-3-3 contains few mutations and retains
the original secondary structure. Monomeric 14-3-3 interacts with phosphorylated target proteins
and has higher chaperone-like activity than dimeric 14-3-3. Further investigation of the properties
of monomeric 14-3-3 is important for understanding its yet poorly characterized role in different
cellular processes.
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V.1. Introduction
The proteins of 14-3-3 family are in focus of many laboratories
since the members of this family interact with hundreds of protein
partners, participate in regulation of many cellular processes like
apoptosis, cell division, transcription, trafﬁcking, etc. and seem to
be involved in pathogenesis of different human disorders [1]. The
raising interest to 14-3-3 proteins can be illustrated by the number
of papers on PubMed published per annum, which was increased
from 12 in 1991 up to 324 in 2011. During such an avalanche-like
accumulation of experimental data, many excellent general re-
views dealing with nomenclature, structure, modes of functioning
and regulation of 14-3-3 were published [1–5]. An interested read-
er can also be addressed to some special reviews considering the
role of 14-3-3 in the nervous system [3] and neurodegeneration
[6,7], involvement of 14-3-3 in the cell cycle control [8,9], in
regulation of cytoskeletal [10] and membrane proteins [11] and
utilization of 14-3-3 as a therapeutic target [12]. The involvement
of 14-3-3 in different processes associated with protein phosphor-
ylation in plants has also been considered recently [13].
The majority of data presented in the literature deal with the
structure and properties of homo- or heterodimers of 14-3-3, i.e.
the forms predominantly presented in the cell. At the same time,
the structure and properties of monomeric forms of 14-3-3, whichal Societies. Published by Elsevier
uchanko).are in equilibrium with dimers and might be transiently accumu-
lated under certain conditions, remain poorly characterized. There-
fore this mini-review attempts to collect and to describe the data
concerning monomers of 14-3-3. We will analyze the beneﬁts of
the dimeric structure and present examples illustrating the neces-
sity of homo- and heterodimers for realization of certain 14-3-3
functions. We also will try to summarize conditions leading to dis-
sociation of dimers and accumulation of monomers, describe the
properties of monomers and speculate on the role of monomers
in 14-3-3 functioning.2. 14-3-3s: a brief outline
It is well-accepted that 14-3-3s perform many of its functions
via homo- and heterodimers formed by different isoforms desig-
nated by Greek letters [2]. Interaction between monomers is
achieved by multiple hydrophobic and polar contacts as well as
several salt bridges whose number depends on the isoform struc-
ture [4]. Such multipoint interaction involves residues of the ﬁrst
four a-helices of 14-3-3 and leads to formation of stable dimers
of a clamp-like shape (Fig. 1A). Each monomer within dimer con-
tains one phosphopeptide-binding site located in the so-called
amphipathic groove (Fig. 1) [14]. This groove includes the side
chains of Lys49, Arg56, Arg127 and Tyr128 (residue numbering
corresponds to f isoform of 14-3-3) [15] (marked green on
Fig. 1B) participating in coordination of phosphorylated serine/
threonine residues located in the consensus motifs of the targetB.V. Open access under CC BY-NC-ND license.
Fig. 1. Structural organization of 14-3-3f. (A) 14-3-3f dimer is formed by two monomers (shown by ribbons in grey and beige) each of which binds phosphopeptide (shown
by spheres in green), top view. Highly ﬂexible C-terminal loop is not shown. (B) Coordination of phosphoserine (orange sticks) of the phosphopeptide ligand (light grey sticks)
is achieved in an amphipathic groove of 14-3-3f which is composed of polar pocket containing positively charged (marked green) and hydrophobic (marked blue) residues.
Ser58 crucial for regulation of 14-3-3f oligomeric state is marked by red spheres. Three segments at the dimer interface originally mutated by Tzivion et al. [65] in order to
produce a dimer-incapable 14-3-3f are shown in magenta. The picture is drawn in PyMol v0.99 using the structure 1QJB of PDB.
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pathic groove is accomplished by hydrophobic interactions with
residues Leu172, Val176, Leu216, Ile217, Leu220, Leu227, and
Trp228 belonging to the C-terminal helices of 14-3-3 [14,18]
(marked blue on Fig. 1B). The same groove can accommodate
unphosphorylated acidic hydrophobic peptides thus increasing
repertory of targets recognized and bound to 14-3-3 [19,20]. How-
ever, this groove seems not to be involved in the chaperone-like
activity of 14-3-3 [21], i.e. its ability to prevent aggregation of par-
tially denatured or disordered partners [21,22] or even dissolve
preformed proteins aggregates [23]. As a result, 14-3-3 proteins
can bind both native predominantly phosphorylated proteins and
disordered/denatured proteins and the binding sites for these tar-
gets are most likely to be structurally different [21].As already mentioned, 14-3-3 predominantly interacts with
phosphorylated proteins, appearance of which is regulated by
hormones and other stimuli. However, this is not the only way of
14-3-3 regulation. It was found that 14-3-3 itself can undergo dif-
ferent posttranslational modiﬁcations (including phosphorylation)
strictly regulating its cellular functions (reviewed by [5]). Phos-
phorylation seems to be the most important way of 14-3-3 regula-
tion and can affect either direct interaction of 14-3-3 with its
targets or induce dissociation of 14-3-3 dimers [5]. As a rule, phos-
phorylation negatively affects interaction of 14-3-3 with its targets.
For instance, phosphorylation of Thr232 inhibits interaction of 14-
3-3 with Raf kinase [24] and arylalkylamine N-acetyl-transferase
(AANAT) [25] and phosphorylation of Ser184 down-regulates
binding of proapoptotic proteins Bax, Bad, c-Abl, FOXO3a to
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14-3-3 isoforms and located at the dimer interface (marked red
on Fig. 1B), provokes dissociation of 14-3-3 dimers and inhibits
interaction of 14-3-3 with p53 [26], Raf kinase [27], cyclin D1
[28], human tau protein and HspB6 (Hsp20) [29], and ASK1 [30].
At the same time, mutation S184E (mimicking phosphorylation
of Ser184 of 14-3-3) led to signiﬁcant increase in the interaction
of 14-3-3f with HspB6 [29] and this is probably the only reported
example when phosphorylation of 14-3-3 is accompanied by in-
crease of target protein binding.
Thus, 14-3-3s form homo- and heterodimers and interact with
predominantly phosphorylated native protein targets and/or with
disordered and partially denatured proteins. Posttranslational
modiﬁcations regulate interaction of 14-3-3 with target proteins
and might affect oligomeric structure of 14-3-3.
3. Dimerization of 14-3-3 and its functional importance
The structure of 14-3-3 dimer is stabilized by many contacts
formed by neighboring subunits [4]. Although the structure of
14-3-3 isoforms is very conservative, the isoforms differ in the pri-
mary structure of the sites involved in the intersubunit contacts.
The variations of the primary structure affect stability and compo-
sition of homo- and heterodimers formed by different 14-3-3 iso-
forms. For instance, variable number of salt bridges can be
formed in the intersubunit contacts of different 14-3-3 isoforms
[4]. The homodimers of b, f, r and s/h isoforms of human 14-3-3
can theoretically be stabilized by three salt bridges. Two salt
bridges can be formed inside of homodimers of c and g isoforms,
and only one salt bridge can be formed inside of e isoform homodi-
mer [4] (the above-mentioned salt bridges are presented twice in
the dimers due to antiparallel symmetry of monomers inside of
the dimer). In addition, the structure of 14-3-3 dimers can be sta-
bilized by transient alternative salt bridges, which are undetect-
able in the crystal structure [31]. All these factors together with
the level of expression will regulate preferences in homo- or het-
erodimer formation.
It is worthwhile to mention, that certain above mentioned salt
bridges are isoform speciﬁc. For example, one of the three salt
bridges formed by 14-3-3r is unique and this, along with the other
features characteristic to this isoform [32], make homodimeriza-
tion of 14-3-3r highly favorable [4,32]. Interestingly, replacement
of these unique residues by residues of the other isoform promotes
14-3-3r heterodimerization [32]. At the same time, theoretically
the structure of 14-3-3e homodimer could be stabilized by only
one salt bridge, whereas inside of heterodimers additional salt
bridges can be formed. This makes formation of heterodimers con-
taining e subunit highly probable [33]. Thus, some human 14-3-3
isoforms (for instance, r) preferentially form homodimers [32],
the other isoforms (for instance, f) form both homo- and heterodi-
mers with ﬁve other isoforms [32], and ﬁnally, some isoforms (for
instance, e) preferentially form heterodimers. Simultaneous
expression of several isoforms of 14-3-3 makes possible formation
of a large variety of homo- and heterodimers in the same tissue
[34] and this, presumably, expands the repertory of 14-3-3
functions.
The target-binding site of different 14-3-3 isoforms is rather
conservative thus leading to partial ability of different 14-3-3 iso-
forms to compensate functions of each other in the cell, unless the
activity of distinct isoforms is controlled by compartmentalization
or other mechanisms [35]. This, however, does not exclude certain
substrate speciﬁcity of 14-3-3 isoforms. For instance, 14-3-3r is
believed to have the highest target speciﬁcity and therefore plays
unique role in cell cycle control [36]. Replacement of the three un-
ique residues of r isoform by alternative residues conserved in theother isoforms (M202I, D204E, H206D mutations) modiﬁes its sub-
strate speciﬁcity providing for binding of CDC25, which is unusual
for the wild type 14-3-3r [36]. Another interesting example is pre-
sented by 14-3-3c, which speciﬁcally interacts with scaffold kinase
suppressor of Ras1 (KSR1) [37]. Binding of 14-3-3 can stabilize the
structure of target proteins and prevent their dephosphorylation or
proteolytic degradation [38,39]. Moreover, 14-3-3s and their yeast
homologues Bmh1p and Bmh2p interacting with corresponding
target proteins can participate in modulation of their enzymatic
activity [40,41].
As already mentioned, 14-3-3s have rather broad substrate
speciﬁcity. Therefore theoretically each monomer inside of
homodimer can bind either identical or different target proteins.
Formation of heterooligomeric complexes becomes especially
probable in the case of 14-3-3 heterodimers. Slightly different sub-
strate speciﬁcity of two monomers inside of 14-3-3 dimer in-
creases the probability of formation of ternary complexes
consisting of two different protein targets and 14-3-3 heterodimer.
Formation of such ternary complexes was postulated for interac-
tion of 14-3-3 with Bcr and Raf kinases [42], with chibby and
b-catenin [43], with tau protein and GSK3b kinase [44], with
integrin-a4 and paxillin [45]. Detection of ternary complexes does
not obligatory mean that 14-3-3 is bridging two different client
proteins. For instance, one cannot exclude the possibility that the
binding of 14-3-3 to the ﬁrst target induces its conformational
changes which are leading to the interaction of the ﬁrst and the
second targets. In the absence of crystal structure revealing direct
14-3-3 bridging two different client proteins one cannot be abso-
lutely sure that 14-3-3 indeed plays a key role in formation of such
ternary complexes. However, if this hypothesis is correct and 14-3-
3 is able to bridge two different client proteins, then this function is
absolutely dependent on 14-3-3 dimerization since each substrate
is bound in phosphopeptide-binding groove located on each of 14-
3-3 monomers. In addition it was also suggested that less conser-
vative outer surfaces of 14-3-3 can also participate in scaffolding of
target proteins [34].
The scaffolding function of 14-3-3 is realized not only by forma-
tion of ternary complexes with two different target proteins. About
50 target proteins contain in their structure several sites recog-
nized by 14-3-3 [19]. The binding of these targets to 14-3-3 most
likely obey the so-called ‘molecular anvil hypothesis’ [46] postulat-
ing that one 14-3-3-binding site (usually having the highest afﬁn-
ity) serves as a gatekeeper and recruits 14-3-3 to the partner. This
interaction is insufﬁcient for modiﬁcation of the structure and
effective regulation of partner’s activity by 14-3-3. Further binding
of the second site of the target to 14-3-3 results in signiﬁcant
changes of target structure and modulation of its activity [46]. This
hypothesis is supported by experimental data indicating that the
peptides containing two phosphorylation sites recognized by 14-
3-3 interact with 14-3-3 much stronger than peptides having only
one recognition site [15,47]. Similar results were obtained with
difopein, a peptide containing two R18 sequences (non-phosphor-
ylated amphipathic peptide tightly interacting with 14-3-3)
connected by a short loop [48]. The data presented mean that
14-3-3 can operate as ‘digital logic gates’ transforming two inputs
into one output [19]. It is worthwhile to mention that some 14-3-3
targets contain even more than two sites with different afﬁnity to
14-3-3 [49–51]. For example, human tau protein regulating
dynamics, stability and functioning of tubulin cytoskeleton [52]
possesses at least three sequences involved in 14-3-3 binding
and all these sequences contain residues, which can be phosphor-
ylated by protein kinase A [51]. The targets having more than two
14-3-3-binding sites can interact with 14-3-3 in a number of
different modes; however, consequences of different types of
interaction remain unknown.
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for performing of scaffolding function of 14-3-3. If 14-3-3 is indeed
able to bridge two different client proteins, then this scaffolding
function is completely dependent on the presence of two indepen-
dent target binding sites located on two monomers inside 14-3-3
dimer. The dimeric structure is also important if the target protein
contains two (or more) 14-3-3 binding sites. Obviously, those part-
ners having only one 14-3-3-binding site in their structure do not
obligatory require 14-3-3 dimerization, unless 14-3-3 dimer binds
to homooligomers, where simultaneous binding of two subunits is
required.4. Monomerization of 14-3-3
Nanoelectrospray ionization mass spectroscopy performed un-
der conditions preserving non-covalent complexes revealed that
all tested human recombinant 14-3-3 isoforms expressed in bacte-
ria are presented in the form of equilibrium mixture of monomers
and dimers and the ratio dimer/monomer is dependent on the iso-
form nature. For instance, some isoforms (e and c) are completely
dimeric, whereas other isoforms (b and g) form a mixture of di-
mer/monomer with the ratio of 70:30 [33]. This is complemented
with the obvious fact that the monomer is obligatory temporary
intermediate of 14-3-3 dimer. To our knowledge, there are no data
on the lifetime of the de novo synthesized 14-3-3 monomer. How-
ever, this lifetime should be enough to meet and detect another
monomer and to form homo- or heterodimers. The rate of subunit
exchange determined in vitro is rather slow and takes hours [33].
This fact indirectly indicates that the lifetime of monomers might
be long enough and that the isolated monomers are not immedi-
ately degraded, although they are less stable to proteolysis than
the corresponding dimers. In addition, it was suggested that under
certain conditions the monomeric forms of 14-3-3 interact with
speciﬁc targets. These intermediate complexes were supposed to
participate in formation of 14-3-3 heterodimers [37]. This attrac-
tive hypothesis is predominantly based on experimental results
obtained under speciﬁc conditions of 14-3-3 overexpression and
its relevance for intact cell requires further investigation. Anyhow,
monomers of 14-3-3 exist in the cell and their amount/concentra-
tion depends on the level of expression and the nature of isoforms,
which determines the equilibrium between monomers and dimers.
Posttranslational modiﬁcation can also affect equilibrium
between monomers and dimers of 14-3-3. For instance, phosphoryla-
tion of g, b, f isoforms of 14-3-3 at Ser58 catalyzed by sphingosine-
dependent protein kinase 1 (SDK1) [53,54], which appears after
proteolytic cleavage of PKCd [55], induces dissociation of 14-3-3
dimers. This mechanism of regulation is applicable only to the
three above mentioned isoforms of 14-3-3 (g, b, and f), since
the other isoforms either do not contain Ser in the corresponding
position, or are not phosphorylated by SDK1 [53,54].
It is worthwhile to mention, that other protein kinases are also
able to phosphorylate Ser58. Thus, PKB/Akt kinase associated with
activation of surviving signaling, phosphorylated Ser58 without
inducing signiﬁcant dissociation of 14-3-3f [56]. At the same time,
phosphorylation of Ser58 by mitogen-activated protein kinase
(MAPK)-activated protein kinase 2 (MAPKAP2) [27] or protein ki-
nase A (PKA) [26] signiﬁcantly compromised 14-3-3f dimerization
leading to formation of 14-3-3f monomers. Dramatic difference in
the results obtained can be due to the different level of Ser58 phos-
phorylation and different protein concentrations as well as to the
different methods used for determination of 14-3-3 oligomeric
state (native gel electrophoresis, chemical crosslinking or co-
immunoprecipitation). Ser58 can also be phosphorylated by a
member of mammalian sterile 20 (Mst) family of kinases, SOK-1,
activated by oxidative stress. This presumably leads to 14-3-3f di-mer dissociation and releases ASK1 kinase triggering cell death
[30]. Thus, phosphorylation of Ser58 of certain 14-3-3 isoforms
in response to activation of different signaling pathways can in-
duce partial dissociation of 14-3-3 dimers.
It should be mentioned that Ser58 is located in the interior of
14-3-3 dimer and therefore is almost inaccessible for modiﬁcation.
At the same time, Ser58 becomes easily accessible in monomeric
forms of 14-3-3. Indeed, the data of Shen et al. indicate that the
monomeric mutant of 14-3-3f is more readily phosphorylated at
Ser58 than the wild type dimeric protein [57]. Phosphorylation of
Ser58 of 14-3-3 monomers will shift equilibrium between mono-
mers and dimers and will lead to further dissociation of dimers
and accumulation of monomers. Conformational changes of the
structure of 14-3-3 can also affect accessibility of Ser58 to protein
kinases and monomer/dimer equilibrium. For instance, we have
found that the T232E mutant (imitating in vivo phosphorylation
of 14-3-3f at Thr232) is more readily phosphorylated by PKA and
undergoes more effective dissociation than the wild type protein
(Sluchanko and Gusev, unpublished data). Therefore we suppose
that hierarchical phosphorylation might also affect the oligomeric
structure of 14-3-3; however this hypothesis needs further exper-
imental support.
A number of small molecules can interact with and affect the
structure of 14-3-3. For instance, sphingosine and its analogues
render 14-3-3 more accessible to phosphorylation at Ser58 and
by this means modulates accumulation of 14-3-3 monomers
[58], whereas arachidonic acid induces dissociation of the complex
of phosphorylated Bad and 14-3-3f and induces aggregation of 14-
3-3 [59].
A novel alternatively spliced variant of 14-3-3e (14-3-3esv) has
been recently described in the literature [60]. This variant is lack-
ing the ﬁrst 22 residues, i.e. the part of the region responsible for
14-3-3 dimerization. mRNA coding this splice variant was detected
in 18 human tissues, but not in the heart tissue [60]. The protein
encoded by this mRNA was unable to form either homo- or hetero-
dimers, but was sufﬁcient to protect the cells against apoptosis
caused by UV-irradiation [60].
Collectively the data described indicate that both monomers
and dimers are present in the cell and that the dimers are not
indispensable to perform some of the functions ascribed to 14-3-
3. This makes important detailed investigation of 14-3-3 mono-
mers, analysis of their peculiarities and probable role.5. Dimer-incapable forms of 14-3-3 and their properties
As already mentioned, 14-3-3s are presented in the form of
equilibrium mixture of monomers and dimers and, as a rule, this
equilibrium is shifted towards dimers. Therefore investigation of
the structure and properties of monomers is possible only after
obtaining of special dimer-incapable forms of 14-3-3. During the
last 15 years several approaches were developed in order to obtain
different monomeric forms of 14-3-3.
First studies used 14-3-3 truncated variants devoid of large
regions of the N-terminus, which are responsible for dimeriza-
tion [61–66]. In order to facilitate puriﬁcation and/or analysis,
these truncated mutants also contained different afﬁnity tags at-
tached to their N-terminus, however these mutants were not
characterized structurally [61–66]. Despite of certain drawbacks,
this approach provided important preliminary information on
the properties of the dimer-incapable 14-3-3 (Table 1). For in-
stance, it was found that dimer-incapable 14-3-3f interacted
with many usual substrates of the wild type 14-3-3 like Raf ki-
nase [62,64,65], Bcr [62], tryptophan hydroxylase [63], platelet
glycoprotein Iba (GPIba) [61]. However, in the case of Raf kinase
interaction with dimer-incapable 14-3-3 was not sufﬁcient for
Table 1
Characterization of different dimer-incapable forms of 14-3-3 presented in chronological order.
Investigated issue Mode of 14-3-3
monomerization
Conclusions Ref.
14-3-3f self-association and Raf binding Truncation Truncated dimer-incapable 14-3-3s bind to Raf kinase similarly to full-
length dimeric 14-3-3, but Raf-kinase is inactive in this complex
[64]
14-3-3g interaction with tryptophan hydroxylase
(TPH), Raf kinase, and Bcr
Truncation Truncated dimer-incapable 14-3-3s containing unmodiﬁed substrate-
binding site were able to bind TPH, Raf, and Bcr in a phosphorylation-
dependent manner; effect of 14-3-3s on the enzymatic activity was not
analyzed
[62,63]
Regulation of Raf kinase by 14-3-3f Point mutation
E5, L12AE, Y82REKIE ? K5,
Q12QR, Q82RENIQa
(7 mutations) or truncation
Monomeric 14-3-3f binds to but cannot regulate Raf kinase activity [65]
14-3-3f interaction with platelet glycoprotein Iba
(GPIba)
Truncation Truncation of the N-terminal segment does not affect interaction of 14-
3-3f with GPIba
[61]
Interaction of 14-3-3f with vimentin Point mutation
E5, L12AE, Y82REKIE ? K5,
Q12QR, Q82RENIQ
(7 mutations)
or truncated mutants
Monomers of 14-3-3f do not bind vimentin in vivo and in vitro [66]
Effect of Ser58 phosphorylation on 14-3-3f
oligomeric state
Direct phosphorylation by
PKB/Akt
Dimerization of 14-3-3 was not altered upon Ser58 phosphorylation by
PKB/Akt
[56]
Effect of Ser58 phosphorylation on 14-3-3f
oligomeric state and its interaction with Raf
Direct phosphorylation by
MAPKAP2 or S58D
mutation
Phosphorylation of Ser58 or S58D mutation compromised 14-3-3 dimer
formation and Raf kinase binding
[27]
Regulation of activity of Drosophila slowpoke Ca-
dependent K-channel (dSlo) by 14-3-3f
Point mutation L15AE and/
or R88VE ? Q15QR and/or
N88VQ
(3, 2 or 5 mutations)
Monomeric 14-3-3 was capable to modulate dSlo channel activity [72]
Effect of Ser58 phosphorylation on 14-3-3f
oligomeric state and phosphopeptide binding
Direct phosphorylation by
SDK1 or S58D mutation
Phosphorylation of Ser58 leads to complete disruption of 14-3-3f dimer,
however, monomers retain phosphopeptide binding ability
[54]
Interaction of 14-3-3f with Raf kinase and DAF-16 Point mutations
E5, L12AE, Y82REKIE ? K5,
Q12QR, Q82RENIQ
(7 mutations)
Monomeric 14-3-3 binds Raf and DAF-16 with the same afﬁnity as
dimeric 14-3-3, but independently of phosphorylation
[57]
Effect of Ser58 phosphorylation on 14-3-3f
oligomeric state and binding of phosphorylated
proteins
Direct phosphorylation by
PKA or S58E mutation
Phosphorylation of Ser58 by PKA or S58E mutation inhibit homo- and
heterodimerization of 14-3-3f and decrease its functional interaction
with p53
[26]
Physico-chemical properties of phosphomimicking
mutants of 14-3-3f and their interaction with
tau protein and HspB6
S58E mutation S58E mutation leads to only partial dissociation of 14-3-3f.
Monomerization of 14-3-3f S58E is accompanied by decrease in its
thermal stability and increased susceptibility to proteolysis. S58E
mutation decreases substrate binding.
[29,67]
Stability of monomeric forms of 14-3-3 in vivo Point mutations
L15AE and/or R88VE ?
Q15QR and/or N88VQ (3, 2
or 5 mutations)
Monomeric mutants of 14-3-3 are proposed to be less stable than dimers
due to a regulated degradation, but not to their intrinsic instability
[71]
Properties of the novel 14-3-3e splicing variant
(14-3-3esv)
Natural 14-3-3 protein
lacking the ﬁrst 22 amino
acids
14-3-3esv is unable to form homo- and heterodimers, but is sufﬁcient to
protect cells against apoptosis caused by UV-irradiation
[60]
Physico-chemical properties of dimer-incapable
mutants of 14-3-3f and their ability to bind tau
protein and HspB6
L12AE ? Q12QR
(3 point mutations)
Minimal number of mutations (3) leads to complete 14-3-3f
monomerization without altering its helical folding. Monomers of 14-3-
3f are intrinsically less stable than dimers, but are able to bind
phosphorylated HspB6 and tau protein. Binding to phosphorylated
HspB6 stabilizes 14-3-3f monomer
[68,69]
a Mutated residues are underlined.
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ble truncated forms of 14-3-3f were unable to bind vimentin
both in vitro and in vivo [66], thus indicating that the binding
to monomeric 14-3-3 is dependent on the nature of a protein
target.The second approach was based on the modiﬁcation of Ser58
facilitating 14-3-3 monomerization. It is well-known that under
experimental conditions it is almost impossible to achieve abso-
lutely speciﬁc and complete phosphorylation of exactly one resi-
due in the structure of protein substrate. This is especially true if
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3-3. Addition of sphingosine can increase effectiveness of Ser58
phosphorylation [58], however in vitro more or less complete
phosphorylation was detected only in the case of monomeric 14-
3-3 [57]. Thus, even after exhaustive phosphorylation only part
of 14-3-3 became phosphorylated and therefore all effects induced
by phosphorylation would be partial. However, this could be
enough to detect certain qualitative effects induced by 14-3-3
phosphorylation. As it was already mentioned, phosphorylation
of 14-3-3 at Ser58 provoked dissociation of 14-3-3 dimers and
inhibited interaction with target proteins, for example, with Raf
kinase [27] and p53 [26] (Table 1).
Replacement of Ser58 by Asp or Glu (S58D or S58E mutations)
results in obtaining of the so-called phosphomimicking mutants,
which are speciﬁcally and completely modiﬁed at the correspond-
ing residue. However, in this case due to the differences in charge
and structure imitation of phosphorylation is not complete. There-
fore phosphomimicking mutants cannot completely reproduce ef-
fects which are characteristic to phosphorylated proteins. Although
this approach has certain disadvantages, it has been helpful to ac-
quire important information. Like phosphorylation, phosphomim-
icking mutation of Ser58 led to dissociation of 14-3-3 dimers
[26,27,29,54,67] and decreased interaction of 14-3-3 with partner
proteins, namely, with Raf kinase [27], p53 [26], human tau pro-
tein, and HspB6 [29] (Table 1). Although these two effects (dissoci-
ation and inhibition of interaction) often correlate with each other
when Ser58 of 14-3-3 is modiﬁed, it is incorrectly to conclude that
inhibition of interaction is a direct result of 14-3-3 monomeriza-
tion. Firstly, the monomeric 14-3-3 retains the intact ligand-bind-
ing site and, secondly, phosphorylation of Ser58 itself can affect
interaction of 14-3-3 with its partners independently of monomer-
ization. Indeed, Ser58 is located in the third a-helix of 14-3-3 in
close vicinity of residues directly involved in phosphopeptide-
binding (Fig. 1B). In this respect it is worthwhile to mention that
S58E mutation decreased [29], whereas monomerization of 14-3-
3f caused by point mutations at the dimer interface (see Fig. 1
and Table 1) increased interaction of 14-3-3f with the small heat
shock protein HspB6 [68,69]. Similarly, 14-3-3f phosphorylated
at Ser58 (or its S58E mutant) had decreased afﬁnity to Raf kinase
[27], whereas dimer-incapable mutant of 14-3-3fwith unmodiﬁed
Ser58 interacted with Raf with the same afﬁnity as the wild type
dimeric 14-3-3f [57] (Table 1). Thus, we conclude that phosphory-
lation of Ser58 itself might affect (inhibit) interaction of 14-3-3
with certain target proteins independently of the oligomeric state
of 14-3-3.
Analyzing the effect of Ser58 modiﬁcation, it is important to
underline that phosphomimicking mutations of this residue are
able to induce only partial dissociation of 14-3-3f. By using differ-
ent techniques we found that the S58E mutant exists as a mixture
of dimers and monomers. The monomer/dimer ratio was depen-
dent on protein concentration, and even at very low protein con-
centration S58E mutant was not fully monomeric [67]. This
indicates that either Ser58 phosphorylation is accompanied by
only incomplete 14-3-3 dissociation, or that S58(E/D) mutation
only partially imitates phosphorylation. In any case, these phos-
phomimicking mutants should not be considered as fully mono-
meric, as it was suggested earlier [31,70].
Since modiﬁcation of Ser58 failed to provide entirely mono-
meric 14-3-3, other approaches have been developed in order to
achieve this goal. Earlier used truncations could induce dramatic
changes of the protein structure. Therefore investigators tried to
reach monomerization by introducing point mutations at the di-
mer interface of 14-3-3 (see Table 1). The ﬁrst such dimer-incapa-
ble 14-3-3 was introduced by Tzivion et al. [65,66] and contained 7
non-conservative amino acid replacements and the N-terminal GST
tag (see Table 1 and Fig. 1B). Later on, the number of mutationswas decreased [71,72], however, in neither case the structure of di-
mer-incapable mutants was analyzed in detail and the question re-
mained, whether the folding of such mutants is correct.
Nonetheless, utilization of such artiﬁcial dimer-incapable mutants
of 14-3-3 provided valuable, although rather contradictory data.
For instance, dimer-incapable 14-3-3s did not interact with phos-
phorylated or unphosphorylated vimentin [66], and at the same
time interacted with Raf kinase and DAF-16 in phosphorylation-
independent manner [57]. Binding of dimer-incapable 14-3-3f
was insufﬁcient for regulation of Raf activity [65] and, at the same
time, dimer-incapable 14-3-3f from Drosophila interacted with
dSlo channel and regulated its activity [72]. Using the same mu-
tants in in vivo Drosophila system Messaritou et al. detected de-
crease of stability of the monomeric 14-3-3f in comparison with
the wild type dimeric protein and proposed that this is due to
the regulated mechanisms of 14-3-3 degradation rather than
intrinsic protein instability [71].
We tried to ﬁnd location and minimal number of mutations
inducing complete monomerization of 14-3-3 [69]. The proteins
with a large number of mutations (6 or 7 point mutations) origi-
nally used by Tzivion et al. [65] were insoluble in prokaryotic
expression system, whereas the proteins with 3 and 4 mutations
were soluble and demonstrated similar properties [69]. According
to the data of CD spectroscopy, these proteins had the same a-heli-
cal structure as the wild type dimeric protein, but remained fully
monomeric in a wide range of protein concentrations [69]. Thus,
we obtained mutants of 14-3-3f (14-3-3fm) which provided a good
model for investigation of the structure and properties of mono-
meric 14-3-3f.
We found that monomeric 14-3-3 is less thermostable and
more susceptible to proteolytic degradation than the wild type
protein [68,69]. The monomeric 14-3-3 speciﬁcally interacted only
with phosphorylated (but not with unphosphorylated) tau protein
and small heat shock protein HspB6 and the binding of phosphor-
ylated HspB6 stabilized the structure of 14-3-3fm [68,69]. 14-3-
3fm possessed higher chaperone-like activity than its dimeric wild
type counterpart [68] and this might be due to higher hydropho-
bicity of the monomeric protein, which is probably caused by
exposition of certain hydrophobic sites earlier involved in the
intersubunit interaction. We hope that characterized in our studies
monomeric mutant of 14-3-3f carrying only three amino acid
replacements (12LAE14?12QQR14) will be useful for identiﬁcation
of important properties of the monomeric 14-3-3f in future.6. Conclusions
14-3-3 are universal proteins performing many functions and
involved in many cellular processes. By interaction with predomi-
nantly phosphorylated protein partners 14-3-3s (i) regulate activ-
ity of many enzymes, (ii) affect subcellular distribution of proteins,
(iii) protect target proteins from proteolysis and dephosphoryla-
tion, (iv) possess chaperone-like activity preventing aggregation
and precipitation of partially unfolded proteins and (v) serve as
adaptors modulating the structure of target proteins and probably
promoting interaction of two protein targets simultaneously
bound to 14-3-3. 14-3-3s are predominantly presented in the form
of homo- or heterodimers and the dimeric structure is of great
importance for performing of scaffolding (adaptor) function of
14-3-3, but it does not seem to be obligatory for the rest of 14-3-
3 functions. 14-3-3 dimers are in equilibrium with monomers
and this equilibrium can be shifted by different stimuli, including
phosphorylation and probably other types of posttranslational
modiﬁcations as well as interaction of 14-3-3 with small mole-
cules. Moreover, certain splice forms of 14-3-3 are lacking the N-
terminal sequence and are unable to form dimers. These make
N.N. Sluchanko, N.B. Gusev / FEBS Letters 586 (2012) 4249–4256 4255desirable investigation of the structure and probable functions of
14-3-3 monomers.
The recently obtained fully monomeric mutant of 14-3-3f con-
taining only three amino acid replacements (12LAE14?12QQR14) re-
tains an unaltered secondary structure and possesses certain
peculiar properties. This mutant has rather unstable structure
which can be stabilized by speciﬁc binding of phosphorylated pro-
tein target. The monomeric mutant interacts with protein targets
in phosphorylation-dependent manner and possesses chaperone-
like activity higher than the wild type dimeric protein. The afﬁnity
of 14-3-3fm to one of its phosphorylated targets, HspB6, is even
slightly higher than that of its dimeric counterpart. Thus, the
monomeric 14-3-3 can fulﬁll many functions ascribed to the di-
meric 14-3-3 and in addition has unique properties. Further inves-
tigations are required for detailed investigation of the structure
and properties of monomeric 14-3-3 and determination of its spe-
ciﬁc role in regulation of different intracellular processes.
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